Ranucci M, Castelvecchio S, Frigiola A, Scolletta S, Giomarelli P, Biagioli B
Department of Cardiothoracic-Vascular Anaesthesia and Intensive Care, IRCCS Policlinico S. Donato, Via Morandi 30, San Donato Milanese, Milan, Italy.
Vox Sang. 2009 May;96(4):324-32. doi: 10.1111/j.1423-0410.2009.01160.x. Epub 2009 Jan 29.
Allogeneic blood products transfusions are associated with an increased morbidity and mortality risk in cardiac surgery. At present, a few transfusion risk scores have been proposed for cardiac surgery patients. The present study is aimed to develop and validate a risk score based on adequate statistical analyses joint with a clinical selection of a limited (five) number of preoperative predictors.
The development series was composed of 8989 consecutive adult patients undergone cardiac surgery. Independent predictors of allogeneic blood transfusions were identified. Subsequently, five predictors were extracted as the most clinically relevant based on the judgement of 30 clinicians dealing with transfusions in cardiac surgery. A predictive score was developed and externally validated on a series of 2371 patients operated in another institution. The score was compared to the other existing scores.
The following predictors constituted the Transfusion Risk and Clinical Knowledge score: age > 67 years; weight < 60 kg for females and < 85 kg for males preoperative haematocrit; gender--female; and complex surgery. At the external validation, this score demonstrated an acceptable predictive power (area under the curve 0.71) and a good calibration at the Hosmer-Lemeshow test. When compared to the other three existing risk scores, the Transfusion Risk and Clinical Knowledge score had comparable or better predictive power and calibration.
A simple risk model based on five predictors only has a similar or better accuracy and calibration in predicting the transfusion rate in cardiac surgery than more complex models.
同种异体血制品输注与心脏手术患者发病率和死亡率增加相关。目前,已针对心脏手术患者提出了一些输血风险评分。本研究旨在通过充分的统计分析并结合对有限数量(五个)术前预测因素的临床选择来开发和验证一种风险评分。
开发系列包括8989例连续接受心脏手术的成年患者。确定了同种异体输血的独立预测因素。随后,根据30名心脏手术输血方面的临床医生的判断,提取了五个最具临床相关性的预测因素。开发了一个预测评分,并在另一机构接受手术的2371例患者系列中进行了外部验证。将该评分与其他现有评分进行比较。
以下预测因素构成了输血风险与临床知识评分:年龄>67岁;女性体重<60kg且男性体重<85kg、术前血细胞比容;性别——女性;以及复杂手术。在外部验证中,该评分显示出可接受的预测能力(曲线下面积为0.71),并且在Hosmer-Lemeshow检验中具有良好的校准。与其他三个现有风险评分相比,输血风险与临床知识评分具有相当或更好的预测能力和校准。
仅基于五个预测因素的简单风险模型在预测心脏手术输血率方面比更复杂的模型具有相似或更好的准确性和校准。